Telescope Financial Statements From 2010 to 2025
| TELIF Stock | USD 0.27 0.02 8.00% |
Check Telescope Innovations financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Telescope Innovations' main balance sheet or income statement drivers, such as , as well as many indicators such as . Telescope financial statements analysis is a perfect complement when working with Telescope Innovations Valuation or Volatility modules.
Telescope |
Telescope Innovations Corp Company Return On Equity Analysis
Telescope Innovations' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Telescope Innovations Return On Equity | -1.69 |
Most of Telescope Innovations' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Telescope Innovations Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Telescope Innovations Corp has a Return On Equity of -1.6921. This is 92.94% lower than that of the Healthcare sector and 95.36% lower than that of the Biotechnology industry. The return on equity for all United States stocks is notably higher than that of the company.
Telescope Innovations Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Telescope Innovations's current stock value. Our valuation model uses many indicators to compare Telescope Innovations value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Telescope Innovations competition to find correlations between indicators driving Telescope Innovations's intrinsic value. More Info.Telescope Innovations Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Telescope Innovations' earnings, one of the primary drivers of an investment's value.About Telescope Innovations Financial Statements
Telescope Innovations stakeholders use historical fundamental indicators, such as Telescope Innovations' revenue or net income, to determine how well the company is positioned to perform in the future. Although Telescope Innovations investors may analyze each financial statement separately, they are all interrelated. For example, changes in Telescope Innovations' assets and liabilities are reflected in the revenues and expenses on Telescope Innovations' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Telescope Innovations Corp. Please read more on our technical analysis and fundamental analysis pages.
Telescope Innovations Corp., a chemical technology company, engages in developing synthetic processes to access pharmaceuticals for the treatment of mental health. Telescope Innovations is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Telescope Pink Sheet
Telescope Innovations financial ratios help investors to determine whether Telescope Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Telescope with respect to the benefits of owning Telescope Innovations security.